The Economic Times

Molbio Diagnostics shares rally 30% in 2 days, jump 80% since debut. What lies ahead?

Molbio Diagnostics shares have surged nearly 30% in two sessions, extending their post-listing gains to around 80% from the IPO price. The sharp rally comes as the newly listed company reported a strong Q1 FY27 performance, swinging to a profit of Rs 58.75 crore from a loss in the year-ago quarter.